GL1X · GenesisL1 explorer

Research workbench

Crystal structure of the catalytic domain of human PARP1 in complex with inhibitor eb-47

Analyse Crystal structure of the catalytic domain of human PARP1 in complex with… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7AAB
Type
protein
Length
700 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Poly [ADP-ribose] polymerase 1
EC
2.4.2.30, 2.4.2.-
UniProt
P09874
Ligands
UHB, SO4
Pockets
5 · best druggability 0.75

Structure

x-ray diffraction · 1 distinct chain · 38% helix, 21% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BPoly [ADP-ribose] polymerase 1 (EC 2.4.2.30, 2.4.2.-)protein35038% helix, 21% strandP09874

Ligands and binding sites

  • UHB · 2-[4-[(2S,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]carbonylpiperazin-1-yl]-N-(1-oxidanylidene-2,3-dihydroisoindol-4-yl)ethanamide · ligand · 2 copies · chains A, B
  • SO4 · Sulfate ion · ion · 4 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17280.750.8061UHB
26480.740.8047UHB
34440.650.7853empty
4580.460.8414empty
51010.440.7918empty

Interfaces

1 interface between chains.

  • A–B · 475 Ų buried · 3 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 1 disulfide (disulfide).

Compared structures

  • 7AAB · Crystal structure of the catalytic domain of human PARP1 in complex with inhibitor EB-47 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.